Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of sunitinib in hormone- and chemotherapy-resistant prostate cancer
2008-005033-29Phase 2Terminated
- Sponsor
- Vassilis Georgoulias, Prof. of Internal Medicine-Oncology of Medical Dpt University of Crete
- Start
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of sunitinib in prostate cancer (PCa), sponsored by Vassilis Georgoulias, Prof. of Internal Medicine-Oncology of Medical Dpt University of Crete. Primary endpoint: Objective response rate. Started Mar 2009; status: terminated.
02
Drugs
sunitinib
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on 2008-005033-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005033-29.